An interventional study of Extracorporeal shock wave therapy and Exercise therapy program in Shock Wave, Traditional Physical Therapy and Chronic Knee Osteoarthritis, sponsored by German International University. Recruiting at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by German International University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 66th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 20 of the 33 other live ones, and was the 78th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 18+
National Cancer Institute, Egypt · Sites in Egypt
Ages 40+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2011; this study’s year is marked. 15 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 62 across the 83 interventional studies, 69 across the 8 observational. Of the 50 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 91 has an industry lead sponsor. The 10 most frequent:
German International University is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
German International University has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
11 of the studies in Osteoarthritis, Knee with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07664371Tanta UniversityCryoneurolysis Versus Radiofrequency in Knee Osteoarthritis | 2026-11 |
| NCT07468734German International UniversityShock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis | 2026-11-30 |
| NCT07666347Tanta UniversityIntraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis | 2026-12-01 |
| NCT07478861Beni-Suef UniversityWhole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis | 2027-02-15 |
Add all 11 to your calendar (.ics) → With an account.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) versus structured therapeutic exercise in patients with chronic knee osteoarthritis (KOA), with respect to pain reduction and improvement of knee function.
Knee osteoarthritis (KOA) is a highly prevalent chronic degenerative joint disease characterized by progressive cartilage loss, chronic pain, stiffness, functional disability, and reduced quality of life in adults, particularly the elderly.
Extracorporeal shock wave therapy (ESWT) has emerged as a non-invasive physical modality that delivers acoustic pressure waves to musculoskeletal tissues, stimulating biological responses such as enhanced microcirculation, anti-inflammatory cytokine modulation, neovascularization, cartilage and bone repair processes, and decreased pain transmission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will receive extracorporeal shock wave therapy.
Other: Extracorporeal shock wave therapy
Patients will undergo a structured exercise therapy program.
Other: Exercise therapy program
Patients will receive extracorporeal shock wave therapy.
Patients will undergo a structured exercise therapy program.
Change in pain intensity
Change in pain intensity will be assessed using the Visual Analogue Scale (VAS) which is a 10-cm horizontal line used to measure pain intensity, ranging from (0) "no pain" to (10) "worst imaginable pain".
Time frame: 5-week after intervention
Stiffness assessment
Stiffness will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.
Time frame: 5-week after intervention
Assessment of physical function
Physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). WOMAC will be recorded at baseline, at the end of the intervention period, and during follow-up. Higher scores indicate greater symptom severity.
Time frame: 5-week after intervention
Knee range of motion
Knee range of motion (ROM) will be assessed.
Time frame: 5-week after intervention
Incidence of adverse events
Incidence of adverse events will be recorded.
Time frame: 5-week after intervention
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 8 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 8 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
German International University